^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AVX901

    i
    Associations
    News

    Trials

    Company:
    AlphaVax
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901 (NCT01526473)
    Phase 1
    H. Kim Lyerly
    Completed
    Last update posted :
    03/29/2018
    Initiation :
    02/01/2012
    Primary completion :
    03/01/2016
    Completion :
    12/01/2017
    HER-2
    |
    HER-2 overexpression • HER-2 expression
    |
    AVX901